Prosecution Insights
Last updated: April 19, 2026

Renagade Therapeutics Management Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18521172 LIPID NANOPARTICLES AND METHODS OF USE THEREOF SHOMER, ISAAC 1612 Non-Final OA Nov 28, 2023
18297346 GENE EDITING COMPONENTS, SYSTEMS, AND METHODS OF USE FRONDA, CHRISTIAN L 1652 Non-Final OA Apr 07, 2023

Managing Renagade Therapeutics Management Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month